Our findings thus complement recent evidence of MBI in preclinical AD and its association with AD biomarkers [61–63] by examining NPS in MCI due to AD and suggest that its severity is not related to the presence of APOE e4 or BDNF Met allele. The gene discussed is BDNF; the disease is Alzheimer disease.